Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Athenex's peak revenue was $144.4M in 2020. The peak quarterly revenue was $46.9M in 2020(q1).
Athenex's revenue increased from $20.6m in 2016 to $102.8M currently. That's a 400.32% change in annual revenue.
| Fiscal year / year | Athenex revenue |
|---|---|
| 2016 | $20.6M |
| 2017 | $38.0M |
| 2018 | $89.1M |
| 2019 | $101.2M |
| 2020 | $144.4M |
| 2021 | $95.4M |
| 2022 | $102.8M |
How accurately did Athenex's revenue projections match actual performance?
Athenex saw the greatest revenue growth in 2018, when revenue increased by 134.21%.
Athenex had the lowest revenue growth in 2021, when revenue changed by -33.95%.
| Year | Athenex growth |
|---|---|
| 2017 | 85%↑ |
| 2018 | 134%↑ |
| 2019 | 14%↑ |
| 2020 | 43%↑ |
| 2021 | -34%↓ |
| 2022 | 8%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2017 | - | $4.6M | $14.0M | $14.9M |
| 2018 | $37.8M | $11.6M | $18.4M | $21.3M |
| 2019 | $25.3M | $22.2M | $19.4M | $34.4M |
| 2020 | $46.9M | $40.2M | $35.5M | $21.8M |
| 2021 | $41.0M | $20.7M | $31.4M | $4.1M |
| 2022 | $29.7M | $31.5M | $33.5M | $8.6M |
Do you work at Athenex?
Did Athenex meet its revenue projections?
| CEO | Mbbs Johnson Y.n. Lau M.D., Frcp |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 575 |
| Date Founded | 2003 |
| Headquarters | Buffalo, New York |
| Number of Locations | 6 |
| Revenue | $102.8M |
| Net Income | -$103,427,000 |
| Gross Proft | $26.7M (2022) |
| Tax Rate | -0.0% |
| Total Assets | $204,055,000 |
| Ticker | ATNX |
Athenex received early financing of $4.1M on 2010-02-03.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $4M | 02/2010 |
| Series Unknown | $4.7M | 04/2011 |
| Series Unknown | $5M | 08/2012 |
| Series Unknown | $300K | 12/2013 |
| Private Equity | $40M | 03/2014 |
| Private Equity | $48M | 05/2015 |
| Post Ipo Equity | $50M | 07/2018 |
| Post Ipo Equity | $100M | 05/2019 |
| Post Ipo Equity | $60M | 12/2019 |
| Investors | Security type |
|---|---|
| Mandra Capital | Series Unknown |
| Mandra Capital | Private Equity |
| Mandra Capital | Private Equity |
| Perceptive Advisors | Post Ipo Equity |
| Perceptive Advisors | Post Ipo Equity |
| OrbiMed Advisors | Post Ipo Equity |
| Kingdon Capital | Post Ipo Equity |
Zippia gives an in-depth look into the details of Athenex, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Athenex. The employee data is based on information from people who have self-reported their past or current employments at Athenex. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Athenex. The data presented on this page does not represent the view of Athenex and its employees or that of Zippia.
Athenex may also be known as or be related to ATHENEX INC., Athenex, Athenex Inc and Athenex, Inc.